acetylcarnitine and carboplatin

acetylcarnitine has been researched along with carboplatin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A	1
Belisle, JA; Engle, DB; Gubbels, JA; Hutson, PR; Kushner, DM; Patankar, MS; Petrie, SE	1
Barbarino, M; Carminati, P; Cavazza, C; D'Incalci, M; Foderà, R; Guglielmi, MB; Milazzo, FM; Orlandi, A; Passeri, D; Perego, P; Petrangolini, G; Pisano, C; Tortoreto, M; Vesci, L; Zucchetti, M; Zuco, V; Zunino, F	1

Trials

1 trial(s) available for acetylcarnitine and carboplatin

Article	Year
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1 Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine	2007

Article

Year

Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.

Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1

Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine

2007

Other Studies

2 other study(ies) available for acetylcarnitine and carboplatin

Article	Year
Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Acetylcarnitine; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cell Growth Processes; Cell Line, Tumor; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Receptor, Nerve Growth Factor; Receptor, trkA	2009
Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Aug-01, Volume: 16, Issue:15 Topics: Acetylcarnitine; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Female; Histone Deacetylase Inhibitors; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2010

Article

Year

Effect of acetyl-l-carnitine on ovarian cancer cells' proliferation, nerve growth factor receptor (Trk-A and p75) expression, and the cytotoxic potential of paclitaxel and carboplatin.

Gynecologic oncology, 2009, Volume: 112, Issue:3

Topics: Acetylcarnitine; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cell Growth Processes; Cell Line, Tumor; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Receptor, Nerve Growth Factor; Receptor, trkA

2009

Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Aug-01, Volume: 16, Issue:15

Topics: Acetylcarnitine; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Female; Histone Deacetylase Inhibitors; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Male; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2010